In this study, we explored whether hyperthermia could enhance the anti-tumour effect of the HSP90 inhibitor 17-DMAG in HCC, and demonstrated that the increased therapeutic benefit of this new strategy in HCC. The gene discussed is HSP90AB1; the disease is hepatocellular carcinoma.